From big fat cells to high blood pressure: a pathway to obesity-associated hypertension

被引:100
|
作者
Pausova, Z
机构
[1] Univ Nottingham, Brain & Body Ctr, Nottingham NG7 2RD, England
[2] Univ Montreal, Ctr Hosp, Res Ctr, Montreal, PQ, Canada
来源
关键词
adipocyte size; hypertension; obesity;
D O I
10.1097/01.mnh.0000214775.42103.a5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review The environment created by modern industrialized societies has caused an unprecedented rise in the prevalence of obesity and obesity-related disorders, including hypertension. Mechanisms that underlie the development of hypertension in obese individuals are not very well understood; they are thought to involve activation of the sympathetic nervous system, the renin-angiotensin-aldosterone system, and oxidative stress. Recent findings Recent research suggests that obesity-associated hypertension may be causally related to the accumulation of 'dysfunctional' adipose tissue characterized by the presence of 'large' lipid-laden adipocytes. Summary Excess energy-intake leads to an expansion of adipose tissue, a hallmark of obesity. But morphology of the expanded adipose tissue differs across individuals, including the size of adipocytes. The presence of 'large' rather than 'small' adipocytes is associated with functional and structural abnormalities of adipose tissue. These include increased production of bioactive molecules, such as leptin, angiotensinogen, pro-inflammatory cytokines, and reactive oxygen species; insufficient capacity to accommodate excess energy-intake leading to ectopic fat storage in tissues and in turn insulin resistance and hyperinsulinemia; and augmented macrophage infiltration enhancing the production of pro-inflammatory cytokines and reactive oxygen species. Such a 'dysfunctional' adipose tissue may, in turn, induce activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system and oxidative stress and, hence, promote the development of obesity-associated hypertension.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 50 条
  • [2] The FTO (fat mass and obesity-associated) gene:: big in adipocyte lipolysis?
    Shoulders, Carol C.
    JOURNAL OF LIPID RESEARCH, 2008, 49 (03) : 495 - 496
  • [3] Changes in short-term variability of blood pressure and heart rate during the development of obesity-associated hypertension in high-fat fed dogs
    Verwaerde, P
    Sénard, JM
    Galinier, M
    Rougé, P
    Massabuau, P
    Galitzky, J
    Berlan, M
    Lafontan, M
    Montastruc, JL
    JOURNAL OF HYPERTENSION, 1999, 17 (08) : 1135 - 1143
  • [4] Hypercortisolism in Obesity-Associated Hypertension
    Varughese, Amy G.
    Nimkevych, Oksana
    Uwaifo, Gabriel I.
    CURRENT HYPERTENSION REPORTS, 2014, 16 (07)
  • [5] Hypercortisolism in Obesity-Associated Hypertension
    Amy G. Varughese
    Oksana Nimkevych
    Gabriel I. Uwaifo
    Current Hypertension Reports, 2014, 16
  • [6] PREVALENCE OF OBESITY, HYPERTENSION AND OBESITY-ASSOCIATED HYPERTENSION IN CHILDREN
    Urbanova, Z.
    Samanek, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 141 - 141
  • [7] Obesity-associated extracellular mtDNA activates central TGFβ pathway to cause blood pressure increase
    Ale, Albert
    Zhang, Yalin
    Han, Cheng
    Cai, Dongsheng
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2017, 312 (03): : E161 - E174
  • [8] Prevalence of hypertension and obesity-associated hypertension in children
    Urbanova, Z.
    Samanek, M.
    JOURNAL OF HYPERTENSION, 2007, 25 : S168 - S168
  • [9] Role of adipokines in obesity-associated hypertension
    Vlasova, M.
    Purhonen, A. K.
    Jarvelin, M. R.
    Rodilla, E.
    Pascual, J.
    Herzig, K. H.
    ACTA PHYSIOLOGICA, 2010, 200 (02) : 107 - 127
  • [10] Leptin Is Not Essential for Obesity-Associated Hypertension
    von Schnurbein, Julia
    Manzoor, Jaida
    Brandt, Stephanie
    Denzer, Friederike
    Kohlsdorf, Katja
    Fischer-Posovszky, Pamela
    Weissenberger, Mario
    Frank-Podlech, Sabine
    Mahmood, Saqib
    Wabitsch, Martin
    OBESITY FACTS, 2019, 12 (04) : 460 - 475